Barreiro P - Search Results

1

First HAART in HIV-infected patients with high viral load: value of HIV RNA levels at 12 weeks to predict virologic outcome.

Townsend D, Troya J, Maida I, Pérez-Saleme L, Satta G, Wilkin A, Barreiro P, Pegram PS, Soriano V, Mura MS, Núñez M. Townsend D, et al. Among authors: barreiro p. J Int Assoc Physicians AIDS Care (Chic). 2009 Sep-Oct;8(5):314-7. doi: 10.1177/1545109709343966. J Int Assoc Physicians AIDS Care (Chic). 2009. PMID: 19759257

2

Patterns of response (CD4 cell count and viral load) at 6 months in HIV-infected patients on highly active antiretroviral therapy.

Barreiro PM, Dona MC, Castilla J, Soriano V. Barreiro PM, et al. AIDS. 1999 Mar 11;13(4):525-6. doi: 10.1097/00002030-199903110-00014. AIDS. 1999. PMID: 10197384 No abstract available.

3

Hydroxyurea plus didanosine as maintenance therapy after 1 year on highly active antiretroviral therapy.

Barreiro P, de Mendoza C, Soriano V, González-Lahoz J. Barreiro P, et al. AIDS. 2000 Jan 28;14(2):207-8. doi: 10.1097/00002030-200001280-00020. AIDS. 2000. PMID: 10708295 No abstract available.

4

Discontinuation of secondary prophylaxis for opportunistic infections in HIV-infected patients receiving highly active antiretroviral therapy.

Soriano V, Dona C, Rodríguez-Rosado R, Barreiro P, González-Lahoz J. Soriano V, et al. Among authors: barreiro p. AIDS. 2000 Mar 10;14(4):383-6. doi: 10.1097/00002030-200003100-00011. AIDS. 2000. PMID: 10770540

5

Risks and benefits of replacing protease inhibitors by nevirapine in HIV-infected subjects under long-term successful triple combination therapy.

Barreiro P, Soriano V, Blanco F, Casimiro C, de la Cruz JJ, González-Lahoz J. Barreiro P, et al. AIDS. 2000 May 5;14(7):807-12. doi: 10.1097/00002030-200005050-00006. AIDS. 2000. PMID: 10839588 Clinical Trial.

6

Emergence of zidovudine resistance in HIV-infected patients receiving stavudine.

de Mendoza C, Soriano V, Briones C, Gallego O, Barreiro P, Alvarez A, González-Lahoz J. de Mendoza C, et al. Among authors: barreiro p. J Acquir Immune Defic Syndr. 2000 Mar 1;23(3):279-81. doi: 10.1097/00126334-200003010-00013. J Acquir Immune Defic Syndr. 2000. PMID: 10839665 No abstract available.

7

[Toxicity associated to efavirenz in HIV-infected persons enrolled in an expanded access program].

Dona C, Soriano V, Barreiro P, Jiménez-Náchera I, González-Lahoz J. Dona C, et al. Among authors: barreiro p. Med Clin (Barc). 2000 Sep 23;115(9):337-8. doi: 10.1016/s0025-7753(00)71549-1. Med Clin (Barc). 2000. PMID: 11093894 Spanish.

8

Induction-maintenance (5 --> 3 drugs) in HIV-infected patients with high viral load.

Soriano V, Barreiro P, Gonzalez-Lahoz J. Soriano V, et al. Among authors: barreiro p. AIDS Patient Care STDS. 2000 Nov;14(11):573-4. doi: 10.1089/10872910050193734. AIDS Patient Care STDS. 2000. PMID: 11155897 No abstract available.

9

Is there a role for indinavir twice-daily in clinical practice?

Barreiro P, Soriano V, Cabello N, González-Lahoz J. Barreiro P, et al. Clin Microbiol Infect. 2000 Mar;6(3):152-4. doi: 10.1046/j.1469-0691.2000.00034-3.x. Clin Microbiol Infect. 2000. PMID: 11168093 Free article. No abstract available.

10

Prevention of nevirapine-associated rash.

Barreiro P, Soriano V, González-Lahoz J. Barreiro P, et al. Lancet. 2001 Feb 3;357(9253):392. doi: 10.1016/S0140-6736(05)71524-5. Lancet. 2001. PMID: 11211023 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

459 results

Search Page

Filters